News-Medical.Net on MSN13d
New three-organ system offers an animal-free alternative for pharmacokinetics research
Innovative organ-on-chip specialist Dynamic42 and ESQlabs, experts in digital life sciences solutions, have successfully ...
Medscape12d
Drug Labels Often Neglect to Inform About Obesity Dosing
Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...
Lighting the way: How activated gold nanoparticles reveal drug movement in the body
Tracking targeted drug delivery is often a challenge due to limitations in current imaging techniques. A recent study by ...
CURE13d
First Patient Dosed With HLD-0915 for mCRPC in First-In-Human Trial
The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...
Healio11d
Two new denosumab biosimilars earn FDA approval
The FDA has approved two new biosimilars of denosumab for all indications of the reference medications Prolia and Xgeva, ...
News-Medical.Net on MSN5d
Breakthrough drug combination targets KRAS mutation in lung cancer
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib-an FDA-approved ...
CURE13d
First Patient With Small Cell Lung Cancer Dosed With Peluntamig
The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.
EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...
FDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugates
A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration ...